Hemostasis Tests - Medical Devices Pipeline Assessment, 2020

1.2 List of Figures

3.1 Hemostasis Tests - Pipeline Products by Stage of Development
3.2 Hemostasis Tests - Pipeline Products by Segment
3.3 Hemostasis Tests - Pipeline Products by Territory
3.4 Hemostasis Tests - Pipeline Products by Regulatory Path
3.5 Hemostasis Tests - Pipeline Products by Estimated Approval Date

4.1 Hemostasis Tests Companies - Pipeline Products by Stage of Development
4.2 Hemostasis Tests - Pipeline Products by Stage of Development

5.1 Alere Inc Company Overview
5.1.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Analyticon Biotechnologies AG Company Overview
5.2.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
5.3 Atantares Corp Company Overview
5.3.1 Atantares Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Atomo Diagnostics Ltd Company Overview
5.4.1 Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 BioMedica USA LLC (Inactive) Company Overview
5.5.1 BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.6 Braun Biosystems, Inc. (Inactive) Company Overview
5.6.1 Braun Biosystems, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.7 Carclo Diagnostic Solutions Ltd Company Overview
5.7.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Diagnostica Stago Inc Company Overview
5.8.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Edan Instruments Inc Company Overview
5.9.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 EKF Diagnostics Holdings Plc Company Overview
5.10.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Emosis SAS Company Overview
5.11.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
5.12 Fraunhofer Institute for Cell Therapy and Immunology Company Overview
5.12.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
5.13 Grifols SA Company Overview
5.13.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
5.14 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
5.14.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
5.15 Helena Laboratories Corp Company Overview
5.15.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
5.16 HemoSonics LLC Company Overview
5.16.1 HemoSonics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.17 Instrumentation Laboratory Co Company Overview
5.17.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
5.18 Levisonics Inc Company Overview
5.18.1 Levisonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Massachusetts General Hospital Company Overview
5.19.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.20 Novametics Inc (Inactive) Company Overview
5.20.1 Novametics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.21 Ortho-Clinical Diagnostics Inc Company Overview
5.21.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 Pakwa Technologies Company Overview
5.22.1 Pakwa Technologies Pipeline Products & Ongoing Clinical Trials Overview
5.23 PortaScience Inc Company Overview
5.23.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Radiometer Medical ApS Company Overview
5.24.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview
5.25 Rappaport Family Institute for Research in the Medical Science Company Overview
5.25.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview
5.26 rHealth Company Overview
5.26.1 rHealth Pipeline Products & Ongoing Clinical Trials Overview
5.27 Roche Diagnostics International Ltd Company Overview
5.27.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.28 Sekisui Diagnostics LLC Company Overview
5.28.1 Sekisui Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
5.29 Siemens Healthcare Diagnostics GmbH Company Overview
5.29.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.30 Siemens Healthcare Diagnostics Inc Company Overview
5.30.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.31 Siemens Healthineers AG Company Overview
5.31.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview
5.32 SonoMedix, Inc. Company Overview
5.32.1 SonoMedix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.33 SQI Diagnostics Inc Company Overview
5.33.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.34 Stichting Lygature Company Overview
5.34.1 Stichting Lygature Pipeline Products & Ongoing Clinical Trials Overview
5.35 Sysmex Corp Company Overview
5.35.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
5.36 Tarabios Company Overview
5.36.1 Tarabios Pipeline Products & Ongoing Clinical Trials Overview
5.37 The Binding Site Group Ltd Company Overview
5.37.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.38 ThromboTherapeutics Inc Company Overview
5.38.1 ThromboTherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.39 Transfusion & Transplantation Technologies (Inactive) Company Overview
5.39.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.40 Universal Biosensors Inc Company Overview
5.40.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of Colorado Company Overview
5.41.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
5.42 University of Michigan Company Overview
5.42.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of Texas Health Science Center at Houston Company Overview
5.43.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview
5.44 University of Vermont Company Overview
5.44.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview

6.1 Nov 12, 2020: Earnings release Q4 FY 2020 : Siemens
6.2 Aug 06, 2020: Earnings release and financial results Q3 FY 2020: Strong team performance in challenging times
6.3 Aug 06, 2020: Siemens profit falls on COVID-19 issues, taxes
6.4 Jul 23, 2020: Abcam: provides full year trading update 2020
6.5 Jul 13, 2020: Judith Wiese appointed managing board member and labor director of Siemens AG
6.6 Jul 13, 2020: Thermo Fisher Scientific and first genetics JCS partner to develop next-generation sequencing-based diagnostics in Russia
6.7 Jul 08, 2020: Michael Peter to be Siemens Mobility’s sole CEO
6.8 Jun 09, 2020: Siemens and Exyte join forces to deliver integrated solutions for fast-track construction of smart biotech facilities
6.9 Apr 14, 2020: Siemens Managing Board sets up COVID-19 aid fund
6.10 Mar 02, 2020: Russia's sanctions-hit Power Machines to sell its stake in JV with Siemens
6.11 Feb 27, 2020: Grifols reaches revenue of EUR 5,100 million, a 13.6% increase, and raises its profits to EUR 625 million
6.12 Feb 27, 2020: SQI Diagnostics reports first quarter 2020 results
6.13 Feb 26, 2020: BioPorto announces preliminary financial result for 2019, guidance for 2020 and postpones publication of audited annual report for 2019 to March 11, 2020
6.14 Feb 26, 2020: Thermo Fisher Scientific President and Chief Executive Officer Marc N. Casper elected Chairman of the Board of Directors
6.15 Feb 24, 2020: 2020 Catalyst award winner Medtronic hires Chief Inclusion and Diversity Officer
6.16 Feb 24, 2020: 2020 Catalyst Award Winner Medtronic hires Chief Inclusion and Diversity Officer
6.17 Feb 18, 2020: Medtronic reports third quarter financial results 2020
6.18 Feb 18, 2020: Hologic Expands Costa Rican operations with new financial shared services center
6.19 Feb 05, 2020: Hologic launches new scalable options for panther system in the United States and Europe
6.20 Feb 03, 2020: Siemens Healthineers starts new fiscal year with strong growth – outlook confirmed
6.21 Jan 30, 2020: Thermo Fisher Scientific reports fourth quarter and full year 2019 results
6.22 Jan 30, 2020: Peter Korte to head Siemens Strategy
6.23 Jan 15, 2020: Accellix announces the appointment of Nir Nimrodi as chairman and chief executive officer
6.24 Jan 14, 2020: ABCAM: Appointment of Chief Financial Officer
6.25 Jan 13, 2020: T2 Biosystems promotes Tony Pare to Chief Commercial Officer
6.26 Jan 12, 2020: Hologic announces preliminary financial results for first quarter of fiscal 2020
6.27 Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance
6.28 Jan 10, 2020: Abcam : Half year trading update
6.29 Jan 09, 2020: rHEALTH Technology granted US patent for small volume blood handling in point-of-care devices
6.30 Jan 09, 2020: T2 Biosystems announces preliminary fourth quarter 2019 financial results
6.31 Jan 09, 2020: T2 Biosystems appoints industry veteran John Sperzel as chief executive officer
6.32 Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter
6.33 Jan 02, 2020: Agilent expands cross-vendor CDS instrument control
6.34 Dec 31, 2019: Redbud Labs expands team in response to increased demand
6.35 Dec 11, 2019: SQI Diagnostics Reports Fourth Quarter and Fiscal 2019 Results and Management Changes
6.36 Dec 10, 2019: Siemens Healthineers gives details on second phase of Strategy 2025 and on the further development of its businesses
6.37 Dec 04, 2019: Lumeon and Medtronic partner to deliver new models of care in Europe
6.38 Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

Table 1: Hemostasis Tests - Pipeline Products by Stage of Development
Table 2: Hemostasis Tests - Pipeline Products by Segment
Table 3: Hemostasis Tests - Pipeline Products by Territory
Table 4: Hemostasis Tests - Pipeline Products by Regulatory Path
Table 5: Hemostasis Tests - Pipeline Products by Estimated Approval Date
Table 6: Hemostasis Tests Companies - Pipeline Products by Stage of Development
Table 7: Hemostasis Tests - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Afinion PT Test - Capillary Blood - Product Status
Table 10: Afinion PT Test - Capillary Blood - Product Description
Table 11: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Coagulyzer 1 - Product Status
Table 13: Coagulyzer 1 - Product Description
Table 14: Coagulyzer 100 - Product Status
Table 15: Coagulyzer 100 - Product Description
Table 16: Coagulyzer 2 - Product Status
Table 17: Coagulyzer 2 - Product Description
Table 18: Coagulyzer 4 - Product Status
Table 19: Coagulyzer 4 - Product Description
Table 20: Atantares Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Platelet Function Assay - Product Status
Table 22: Platelet Function Assay - Product Description
Table 23: Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 24: AtomoRapid - Coagulation Monitoring - Product Status
Table 25: AtomoRapid - Coagulation Monitoring - Product Description
Table 26: BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Portable Diagnostic System - Hemostasis - Product Status
Table 28: Portable Diagnostic System - Hemostasis - Product Description
Table 29: Braun Biosystems, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Bio6 - Product Status
Table 31: Bio6 - Product Description
Table 32: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Micropoc-CAT - Haemostasis Assay - Product Status
Table 34: Micropoc-CAT - Haemostasis Assay - Product Description
Table 35: Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Calibrated Automated Thrombogram - Thrombin Assay - Product Status
Table 37: Calibrated Automated Thrombogram - Thrombin Assay - Product Description
Table 38: STA Compact Max - NeoPTimal ISI - Product Status
Table 39: STA Compact Max - NeoPTimal ISI - Product Description
Table 40: STA Compact Max - Ristocetin Cofactor Assay - Product Status
Table 41: STA Compact Max - Ristocetin Cofactor Assay - Product Description
Table 42: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Status
Table 43: STA Compact Max - Rivaroxaban Calibrators And Controls For Anti-Xa - Product Description
Table 44: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Status
Table 45: STA-R Evolution Expert - Automated Ecarin Chromogenic Assay - Product Description
Table 46: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Status
Table 47: STA-R Evolution Plus - Automated Ecarin Chromogenic Assay - Product Description
Table 48: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Status
Table 49: STA-R Evolution Plus - Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa - Product Description
Table 50: STA-R Max - NeoPTimal ISI - Product Status

Figure 1: Hemostasis Tests - Pipeline Products by Stage of Development
Figure 2: Hemostasis Tests - Pipeline Products by Segment
Figure 3: Hemostasis Tests - Pipeline Products by Territory
Figure 4: Hemostasis Tests - Pipeline Products by Regulatory Path
Figure 5: Hemostasis Tests - Pipeline Products by Estimated Approval Date